Do Traders Think Surface Oncology Inc (SURF) Can Turn Around Friday?

Friday, May 27, 2022 11:00 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Surface Oncology Inc (SURF) Can Turn Around Friday?

The market has been down on Surface Oncology Inc (SURF) stock recently. SURF gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Surface Oncology Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SURF!

See Full SURF Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SURF Stock Today?

Surface Oncology Inc (SURF) stock is trading at $1.84 as of 10:56 AM on Friday, May 27, an increase of $0.01, or 0.82% from the previous closing price of $1.82. The stock has traded between $1.70 and $1.85 so far today. Volume today is below average. So far 374,878 shares have traded compared to average volume of 720,009 shares. To screen for more stocks like Surface Oncology Inc click here.

More About Surface Oncology Inc

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States. Click Here to get the full Stock Report for Surface Oncology Inc stock.